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The Leukaemia is a very common cancer worldwide, and different drugs have been applied to treat 
leukaemia. However, the influence of the drugs on the biomechanical properties of leukaemia cells, 
which are related the risk of leukostasis, is still unknown. Moreover, accurate measurement of 
biomechanical properties of leukaemia cells is still a challenging task because of their no-adherent 
nature and high sensitivity to the surrounding physiological conditions. In this study, a protocol to 
measure the biomechanical properties of leukaemia cells by performing indentation tests using optical 
tweezers is proposed. The biomechanical properties of normal leukaemia cells and cells treated with 
various cancer drugs, including phorbol 12-myristate 13-acetate (PMA), all-trans retinoic acid (ATRa), 
Cytoxan (CTX) and Dexamethasone (DEX), were measured. The adhesion between the cells and 
certain proteins existing in the extracellular matrix, i.e. fibronetin and collagen I, was also 
characterized with the help of a static adhesion assay. It was found that after treatment by ATRa, CTX 
and DEX, the cells became softer, and the adhesion between the cells and the proteins became weaker. 
PMA treatment caused no change in the stiffness of the HL60 cells, but increased the stiffness of the 
K562 cells, and increased the cell-protein adhesion of both K562 cells and HL60 cells. 
Keywords: optical tweezers, indentation, Leukaemia cells, cell mechanics 
1.   Introduction 
The biomechanical properties of cells are directly 
determined by their protein structures and thus closely 
related to their biochemistry and genetics. Therefore, 
physiological changes caused by various diseases in 
the human body may result in alteration of the cells’ 
biomechanical properties
1
. For example, the 
chondrocytes suffering from osteoarthritis are 
generally less stiff than normal chondrocytes
2
, and it 
was also reported that cancer cells can deform more 
easily than normal cells
1
. To study the biomechanics 
of cells may therefore be helpful in revealing 
quantitative information about the progression of 
certain diseases
1, 3
. 
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Leukaemia is a cancer of the blood or bone 
marrow due to an abnormal proliferation of blood cells, 
usually white blood cells. It can be classified into two 
groups: acute and chronic leukaemia
4
. Acute 
leukaemia is caused by the rapid increase of immature 
blood cells, the malignant cells rapidly progress and 
accumulate in the human body, split over into 
bloodstream and then spread out to other organs. 
Chronic leukaemia is due to the excessive build-up of 
relatively mature, but still abnormal, white blood cells. 
Studies have been done to investigate the cell 
mechanics of leukaemia
4-7
. Tsai et. al. employed 
micropipette aspiration to investigate the deformability 
of HL60 cells at different cell cycles and found that 
the HL60 cells at G1 cycle is less stiff than in G2/M 
cycles
8
. Rosebluth et al used atomic force microscopy 
(AFM) nanoindentation to measure the biomechanical 
properties of HL60, Juket cells etc., and found that 
their biomechanical properties are related to the risk of 
leukostasis, a complication of leukaemia, and a major 
reason to cause death, due to the heavy aggregation of 
leukaemia cells inside the blood vessels
9
. Lam et. al 
investigated the stiffness of leukaemia cells, and found 
that their stiffness increased more than 100 times after 
treated with DEX. They therefore suggested that the 
DEX will have the chance to increase the risk of 
leukostasis
7
. It was also reported that the adhesion 
between the leukaemia cells and their extracellular 
matrix plays an important role in leukostasis, 
especially for acute myeloid leukaemia
10-12
, in which 
the escape of leukaemia cells from bone marrows is 
determined by the adhesion between the bone marrow 
fibroblasts and the cells
13, 14
. 
Accurate measuring the biomechanical properties 
of leukaemia cells is challenging, due to the 
difficulties in simulating the in vivo conditions of the 
cells and their non-adherent nature. The results for the 
single cell mechanics of leukaemia reported so far 
suffer from large scattering and are debatable
9, 15
.  The 
previously used techniques of micropipette and AFM 
nanoindentation both have their short comings. In 
AFM nanoindentation, an AFM tip is used as a probe 
to indent on the cells. Based on the mechanical 
response recorded during the indentation, the 
mechanical properties of the cells can be extracted
1, 9
, 
16
, but it is well known that the properties of the cells 
are closely related to the physiological conditions, e.g. 
the pH value, the temperature and even the 
atmosphere
9
, and it is difficult to build up an 
experimental setup that can completely simulate the 
physiological conditions of the human body on an 
AFM. In a micro-pipette system, normally the cells are 
aspired by the pipette and their deformation is 
recorded and analyzed to evaluate deformability. 
However, the shapes of cells are usually irregular, and 
this limits the accuracy of the measurement because 
precise knowledge of the cells’ shape is required in the 
calculation. 
Optical tweezers are a novel technique for 
manipulating small objects. In this technique a focused 
laser beam is utilized to provide an attractive or 
repulsive force to physically hold and move micro-
particles
17, 18
. Because of its feasibility to perform test 
on biological samples in physiological conditions, it 
has been adopted by the biological community for cell 
manipulation, isolation, etc
19-21
. Meanwhile, the 
feasibility of using the optical tweezers to study single 
cell mechanics has been demonstrated recently
3, 22-24
: 
the most pronounced study was to use optical tweezers 
to perform tensile tests on red blood cells suffering 
from malaria to investigate their deformability
3, 22
. 
Comparing with AFM nanoindentation, optical 
tweezers do not need direct physical contact with the 
“probe” to apply a force on them, and so the tests can 
be performed in a completely isolated container, thus 
enabling physiological conditions very close to those 
in the human body to be easily achieved. In the 
previous study by Suresh et. al
3
, tensile tests were 
performed with the help of optical tweezers, but in this 
method, the maximum applied force is actually 
determined by the interaction force between the micro 
beads and cells, which is usually in tens of 
piconewtons. Such small forces may not be able to 
generate significant deformation in cells stiffer than 
red blood cells. 
In this work, a new protocol to evaluate the 
deformability of cells by performing indentation tests 
using optical tweezers is developed. Currently, 
different drugs have been developed to treat leukaemia, 
but their influence on the mechanical properties of 
leukaemia cells, which should be closely related to the 
risk of leukostasis, has not yet been fully understood. 
For this reason, we applied the optical tweezers 
indentation protocol to measure the biomechanical 
properties of leukaemia cells, in order to study the 
influence of different drugs on the biomechanical 
properties of the treated cells. Apart from the 
mechanical testing, the cell-fibronetin and cell-
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collagen I adhesion was also studied with the purpose 
to better evaluate the relationship between the drug-
treatment and the risk of leukostasis. 
2.   Experimental details 
2.1.   Cell culture  
In this study, the HL60 and K562 cells were used as 
models for acute and chronic leukaemia respectively. 
The incubator used is a Bionex
@
 type. The cells were 
cultured in RPMI 1640 containing 10% fetal bovine 
serum, and the atmosphere inside the incubator was 
humidified and maintained in 5% CO2 at 37 
o
C. 
2.2.   Optical tweezers  
The optical tweezers used in this study are a MMI 
Cellmanipulator System supplied by MMI Company 
in Switzerland. This machine is specially designed by 
MMI to enable laser trapping to be performed with a 
maximum laser power of 8W (Nd:YAG laser, 
wavelength 1064 nm). The laser focus was adjusted 
following the standard calibration procedure suggested 
by the supplier before the experiments. A microscope 
stage incubator (Okolab Company, Italy) was 
integrated into the optical tweezers system which 
enables control of the experimental conditions, such as 
the atmosphere and temperature.  
2.3.   Laser power-force calibration  
The relationship between the applied laser power and 
the generated maximum laser trapping force must be 
carefully calibrated before the mechanical testing.  A 
calibration method integrated into the optical tweezers 
system, which involves estimating the maximum 
viscous drag force exerted by the fluid when the 
trapped particle just breaks loose from the trap during 
oscillation by it, was employed in this study
25
. 
Typically a calibration procedure is as follows: first, 
the laser is focused and used to trap a microsphere at a 
given laser power. Then the trapped microsphere is 
vibrated periodically by rocking the laser beam. The 
frequency and amplitude of the vibration are increased 
gradually until the laser cannot hold the microsphere. 
The critical frequency  and amplitude Ac are then 
used in the follow equation,  
 
 
 caAtxF
2
max 6),(  , (1) 
to calculate the maximum laser trapping force
25
. Here 
  is the dynamic viscosity of the solution and a is 
the radius of the microsphere. Fig. 1 shows the 
calibrated plot of laser power vs. maximum trap force, 
which was achieved by vibrating microspheres in the 
culture medium mentioned above. Clearly, the 
maximum trapping force increases linearly with 
increasing laser power, in agreement with previously 
reported result
25
.   
2.4.   Cancer drugs testing 
The leukaemia cells were divided into 5 groups. One 
of them was used as control, and the other four were 
treated by different common drugs for leukaemia, 
including the two differentiation therapy drugs, 
namely, phorbol 12-myristate 13-acetate (PMA) with a 
concentration of 10 g/L and all-trans retinoic acid 
(ATRa) with a concentration of 1 M/L, as well as 
two chemo-therapy drugs, namely, Cytoxan (CTX) 
with a concentration of 0.1 M/L and Dexamethasone 
(DEX) with a concentration of 20 g/L. These drugs 
were applied to the 4 groups for 24 hours before 
mechanical testing. 
2.5.   Cell structure observation  
Scanning electron microscopy (SEM) and fluorescence 
microscopy were used to study the morphology and 
 
Fig. 1.   The relationship between the laser power and maximum 
trap force calibrated by the viscous drag method. 
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the structure of the cells. The SEM used is a Hitachi 
S4800 FEG SEM and the fluorescence microscope 
used is a Nikon Ti-E inverted microscope integrated 
into the optical tweezers system. 
 
2.6.   Static adhesion assay 
96 well microplates (BD Falcon MicroTEST
TM
 96) 
were pre-coated with 4 g/ml fibronetin (sigma, from 
human plasma) and collagen I (sigma, from rat tail) 
respectively overnight at 4 
o
C, then washed twice with 
PBS buffer, blocked by 1% BSA in PBS buffer at 
37
o
C for 1 hour and then washed again. K562 and 
HL60 cells were cultured with the drugs in 2 hours and 
24 hours. The cell density was counted by 
haemocytometer to be 2.5× 10
6
 cells/mL. 100 mL drug 
treated and untreated cells were added into each well 
and incubated at 37
o
C for 30 minutes. The cells inside 
the wells were gently washed with PBS twice, fixed 
with 2.5% glutaraldehyde and incubated at room 
temperature for 10 minutes, and then they were 
washed again and stained with 0.5% crystal violet in 
20% methanol for 10 minutes. The stained cells were 
washed with water gently and immersed with 10% 
acetic acid on an orbital shaker (Heidolph Vibramax 
100) for 5 minutes. Finally the cells inside the 
microplates were measured by a Bio-Tek instruments 
EL808 microplate reader at wavelength 550 nm. 
 
2.7.   Optical tweezers indentation 
Indentation tests were performed on the cells with the 
help of the calibrated optical tweezers mentioned 
above. Before doing the indentation, the cells were 
transported from the large Bionex
@
 incubator to the 
microscope incubator integrated into the optical 
tweezers system. All the indentation tests were 
performed in this isolated microscope incubator 
thereafter. The temperature as well as the atmosphere 
during the mechanical testing could therefore be well 
controlled. The culture medium inside the microscope 
incubator was RPMI 1640 containing 10% fetal bovine 
serum, which served to maintain the cells’ normal 
physiological behaviour. The bottom of the 
microscope incubator, which actually is a transparent 
glass slip, was coated with fibronetins by culturing 
with PBS containing 0.1 g/mL fibronetins for 24 
hours at 37
o
C, and so on it the leukaemia cells could 
be attached firmly. The microspheres used in this 
study were supplied by Polysciences, Inc. They were 
made of polystyrene and had diameters in the range 
2.49±0.02 microns. The typical indentation procedure 
is as follow: first, the microscope’s focal plane was 
adjusted to overlap with the largest circular section of 
the cell under study.  Then, a microsphere was laser-
trapped with a given laser power and it was then 
brought to contact with the cell.  The microsphere was 
then indented into the cell slowly by moving the 
motor-driven sample stage toward the trapped 
microsphere at a velocity of around 1 m/s. The 
critical indentation depth as well as the corresponding 
laser power at which the microsphere broke loose from 
the trap was then recorded. In this protocol, since the 
indentation depth is larger than the radius of the 
microsphere, the microsphere-cell contact radius 
should always be equal to the radius a of the 
microsphere. The contact stiffness, S, is therefore 
 
 
where hmax is the indentation depth at which the laser 
trap was lost, and can be directly measured based on 
the recorded microscope images; Pmax is the 
corresponding applied force, and can be calculated 
from the laser power based on the calibration results 
shown in Fig. 1. The elastic moduli E of the cells, can 
therefore be obtained by the equation 
 
 
where a is the contact radius which is equal to the 
radius of microsphere used, and v is the Possion’s ratio  
which is assumed to be 0.5. 
Mechanical testing was performed on the drug-
treated cells 24 hours after the drug were applied to the 
cells. For each cell group, tests were performed on 12 
randomly selected cells. Experiments were also 
performed on an individual group of K562 cells at 
different time points to investigate the biomechanical 
properties of the cells during their life cycles. 
 
3.   Results and discussion 
 
Fig. 2 and 3 show the SEM images of K562 and HL60 
cells before and after the drug treatment respectively. 
For the CTX and DEX group, no significant change in 
morphology was observed, because the major function 
of these two types of drug is to directly kill the 
leukaemia cells. However, for the leukaemia cells 
treated with PMA and ATRa, their morphology 
changed significantly. For example, some K562 cells 
treated with PMA became elongated (Fig.2e) and 
some HL60 cells treated with PMA expanded and 
stuck to the substrate (Fig. 3e). This might be due to a 
change of adhesion and cytoskeleton, making the cell 
more adhesive and therefore easier to attach on a 
substrate. This should also be due to the nature of the 
drugs applied: the PMA and ATRa are differentiation 
therapy drugs and will lead to the differentiation of 
leukaemia cells.  
maxmax / hPS   
 (2) 
 
(3) 
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Fig. 4 and 5 show the HL60 and K562 cells stained 
with Hoechst 33342 (Sigma), which is commonly used 
to make DNA visible under the fluorescence 
microscope. It can be seen that the nuclei in the CTX 
and DEX treated cells showed a condensed shape with 
part of the DNA fragments spread in the cytoplasm, 
indicating the feature of apoptosis, while the control 
group and the leukemic cells treated with PMA 
showed homogeneous nuclei and not DNA in the 
cytoplasm. The cells were also stained with phalloidin 
to observe the distribution of F-actin under the 
fluorescence microscope. It was found that the cells 
treated with CTX and DEX became less condense than 
the control group. Both the SEM and the fluorescence 
microscope study indicate that the drugs affect the 
cells efficiently 24 hours after the treatment. 
 
 
    The cell-protein adhesion was characterized by a 
static adhesion assay, and the results are shown in Fig. 
6. Here we classify the cells into three groups: normal 
cells, the cells exposed to drugs for 2 hours and 24 
hours respectively. Results from the negative control 
group, i.e. adhesion between the leukaemia cells with 
drug-treatment and BSA, are also reported. It can be 
seen that K562 cells showed stronger binding to the 
proteins comparing with HL60 in all the results 
reported here, and this may also suggest that the 
 
Fig. 2 SEM images of K562 cells. (a) shows the normal K562 
cells; (b) - (e) show the K562 cells after the treatment of CTX, 
DEX, ATRa and PMA respectively. 
 
Fig. 4. Fluorescence microscope images of normal K562 cells and 
drug-treated K562 cells. On the left side are cells stained with 
hoechst to observe the nucleus and on the right side are cells 
stained with phalloidin to observe the distribution of F-actin. 
 
Fig. 3 SEM images of HL60 cells. (a) shows the normal 
HL60 cells; (b) - (e) show the Hl60 after the treatment of 
CTX, DEX, ATRa and PMA respectively. 
6 Z. L. Zhou et al. 
chronic leukemic cell K562 is a more mature cell type 
than the acute leukemic cells HL60. The HL60 cells, 
as less adhesive leukemic cells, should therefore be 
easier to flee away from the bone marrow extracellular 
matrix. In the CTX and DEX drug treatment groups, 
the adhesion of both K562 and HL60 cells decreased 
rapidly, from 2 hours treatment to 24 hours treatment, 
indicating that CTX and DEX have a reverse effect on 
the cell-protein adhesion, and it is suspected that this 
may be caused by the cell apoptosis
26
. Cells treated 
with PMA show different behaviour – the cell-
fibronetin and cell-collagen adhesion increases for 
both HL60 and K562 cells. This may also indicate that 
PMA may be helpful in slowing down the releasing 
process of leukaemia cells into the blood stream, by 
increasing the adhesion between the acute leukemic 
cells and the bone marrow extracellular matrix. 
Fig. 7 shows the optical microscope images taken 
during the indentation procedure and fig. 7-d shows 
the image just before the loss of the laser trap. The 
measured elastic moduli of normal K562 and HL60 
cells and the cells treated with different drugs are 
listed in Table 1. It can be seen that the normal HL60 
cells show higher elastic moduli than K562 cells, i.e. 
the HL60 cells are less deformable than the K562 cells. 
It was reported that the risk of leukostasis of chronic 
leukaemia patients is smaller those suffering acute 
leukaemia
9, 27
, and so the elastic moduli measured here 
for normal leukaemia cells agree with this finding, if 
leukostasis is linked to increased stiffness. The elastic 
moduli of normal HL60 cells was measured as 
 
Fig. 6. Adhesion between the leukaemia cells and the extracellular 
matrix proteins measured with static adhesion assay (n=6). (a) and 
(b) show the cells-fibronetin adhesion and cell-collagen I adhesion 
respectively. The adhesion between protein and cells treated with 
different drugs at time points of 2 hours and 24 hours are shown. 
The ‘no drugs’ groups show the adhesion of proteins and 
leukaemia cells without drug-treatment, and the “NC” group is the 
negative control of leukaemia cells without drug-treatment tested 
in BSA- blocked well. 
 
Fig. 5. Fluorescence microscope images of normal HL60 cells and 
drug-treated HL60 cells. On the left side are cells stained with 
hoechst to observe the nucleus and on the right side are cells 
stained with phalloidin ato observe the distribution of F-actin. 
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213.1±21.4 Pa, which is significantly lower than the 
855±670 Pa measured with AFM nanoindentation 
previously
9
, but the results reported previously have 
large scattering presumably because a larger sample 
size of 60 was used, and the elastic moduli measured 
here are still in the range of the previously report ones, 
albeit with much less scattering. It therefore seems that 
the present measurement protocol is more reliable. 
It was found that almost all the drugs will 
significantly influence the biomechanical properties of 
the leukaemia cells. For the cells treated with CTX and 
DEX, which are chemical drugs to kill the leukaemia 
cells, the foggy images of nucleus as well as the loss 
of cytoskeleton structure shown in Fig. 4 and 5 
indicate the apoptosis of the cells, and so it is not 
surprising that the measured elastic moduli of both 
K562 and HL60 after drug treatment are smaller than 
those measured from normal leukaemia cells. The 
PMA and ATRa will induce the leukaemia cells to 
differentiate, and the condensed nuclei of the cells 
treated with these two drugs indicate that the cells are 
still in a healthy state. However, the cells’ structure 
were actually affected by the drugs, for instance, the 
nuclei became smaller for the ATRa treated HL60 
cells. Our measurement shows that all the cells treated 
with ATRa became less stiff, but cells treated with 
PMA either exhibited no significant change in stiffness 
(HL60), or actually an increase in stiffness (K562). 
The increase of stiffness of K562 cells after PMA 
treatment might be related to the change of their shape 
and cytoskeleton after the drug treatment (c.f. Fig. 2-e). 
Noticeable scattering of the elastic moduli 
measured from each group of cells was found. Since it 
was reported that the leukaemia cells in different life 
cycle phase will have different mechanical properties, 
a control experiment was conducted using K562 cells. 
In this experiment, first the cell synchronization was 
done by culturing the cells in RPMI 1640 without fetal 
bovine serum at the same atmosphere conditions for 
24 hours
9
, and then the synchronized cells were 
cultured in the microscope incubator with the normal 
culture medium for another 24 hours. Their 
mechanical properties were measured every 2 hours 
when culture with normal culture media. The 
measured elastic moduli are shown in Fig. 8. 
Interestingly, we found that scattering of the 
measured elastic moduli increases with the time, and 
the lower limit of the measured results is more or less 
 
Fig. 7. Microsphere images taken during an indentation test performed by optical tweezers. 
 
 Table 1. The measured elastic modulus of leukemia cells with and 
without drug treatment (n=12, Mean±SD, Pa).. 
 
 Fig. 8 Elastic modulus of normal K562 cells measured at 
different time points within 24 hours after cell synchronization. 
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the same during the 24h period while the upper limit 
increases rapidly with time. The cell doubling time for 
a K562 cell to shift from the G1-M phase is around 24 
hours
28
, and the speed to shift the cell life cycle will be 
different between individual cells. It is therefore 
believed that with the increase of time, the originally 
synchronized cells inside the incubator evolved into 
different life cycle phases, and this causes the 
increasing scatter. It was reported previously that the 
HL60 cells will become stiffer following the life cycle 
G1->S->G2/M8, and the results shown in Fig. 8 
indicate that the K562 cells also become stiffer when 
as they enter later phases in their life cycle, just as 
HL60 cells. The drug-treated cells should actually be 
in different life cycle phases when they were 
mechanically tested, because the tests were performed 
24 hrs after the drug treatment. It is therefore believed 
that the scattering found in the elastic moduli 
measured from the drug-treated cells should be 
partially caused by differences in the different cells’ 
life cycles. 
In our experiment, the microsphere used was 
around 2.5 m in diameter, and the size of the cells 
was in the range from 10 m-20 m in diameter. 
Therefore, the microsphere can only deform the cell 
partially and the results measured should be local 
properties. Actually, the local elastic moduli of HL60 
measured in this study agree with those measured with 
AFM indentation in previous study
9
. Our results still 
have quite significant scatter, although this is smaller 
than those reported previously with AFM 
nanoindentation
9
. The scatter may be due to the 
inhomogeneous nature of the cells. The changes in 
mechanical properties of HL60 cells treated by DEX 
were reported previously by Lam et al.
7
, and the DEX 
cells’ stiffness was found to increase by more than 100 
times after exposure to DEX for 6 hours. This is totally 
different from the stiffness of DEX treated HL60 cells 
measured in our work. This discrepancy may be due to 
the differences of the measurement techniques. In Lam 
et al.’s work, AFM nanoindentation tips were used, 
and therefore the stiffness of cells measured should 
represent the surface properties of the cells. However, 
in our experiment, we deformed the cells with 
microspheres with a diameter of around 2.5 m, and 
so the elastic modulus measured should closely relate 
to the cytoskeleton structure of the cells or the size of 
cell’s nucleus.  
The long-term laser operation will influence the 
cell’s growth and division, as reported by Ayano et al. 
in 2006
29
. However, in our study, the laser was not 
directly shot on the cells, and the time of the contact 
between the laser trapped bead and the cell was very 
short at typically less than 1 min. Therefore, it is 
believed that the influence of laser in this study is 
negligible. 
It should be admitted that the current protocol may 
not be very accurate, since the cells’ deformation 
during indentation should actually be viscoelastic, but 
in our protocol, viscoelasticity is not considered
30, 31
. 
The current experimental technique can also be further 
improved. For example, if a photodiode bead detection 
system is installed in the optical tweezers, the 
movement of the bead and the force applied onto the 
cells can be accurately monitored, and the recorded 
force-displacement curve can therefore be analyzed by 
certain viscoelasticity correction protocol to extract the 
elastic modulus accurately.  
4.   Conclusions 
In this study, a new protocol was proposed to measure 
the mechanical properties of leukaemia cells under 
well controlled physiological conditions by performing 
indentation test using optical tweezers. The proposed 
method was employed to measure the elastic moduli of 
the normal HL60 and K562 cells, and their 
counterparts treated with four different drugs PMA, 
ATRa, CTX and DEX. The measured elastic moduli of 
K562 and HL60 cells are 162.8±19.2 Pa and 
213.1±21.4 Pa respectively. These measured moduli 
agree with the previously reported relationship 
between the deformability of leukaemia cells and the 
risk of leukostasis, and also agree with previously 
measured elastic moduli of HL60 cells by AFM 
nanoindentation. It was found that the ATRa, CTX and 
DEX drugs all decreased significantly the stiffness of 
the leukemia cells, and so they possibly can decrease 
the risk of leukostasis. PMA treatment, however, 
resulted in no change of stiffness of HL60 cells, or 
actually increased the stiffness of K562 cells. A static 
adhesion assay was employed to investigate the 
adhesion between the cells and proteins existing in 
their extracellular matrix. It was found that cells 
treated with ATRa, CTX and DEX showed weaker 
  The Biomechanics of Drug-treated Leukaemia Cells Investigated Using Optical Tweezers 9 
cell-protein interaction, while those treated with PMA 
showed stronger cell-protein interaction, than the cells 
without drug treatment. 
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